Merlini G - Search Results

1

Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies.

Burgos L, Tamariz-Amador LE, Puig N, Cedena MT, Guerrero C, Jelínek T, Johnson S, Milani P, Cordon L, Perez JJ, Lasa M, Termini R, Oriol A, Hernandez MT, Palomera L, Martinez-Martinez R, de la Rubia J, de Arriba F, Rios R, Gonzalez ME, Gironella M, Cabañas V, Casanova M, Krsnik I, Perez-Montaña A, González-Calle V, Rodriguez-Otero P, Maisnar V, Hajek R, Van Rhee F, Jimenez-Zepeda V, Palladini G, Merlini G, Orfao A, de la Cruz J, Martinez-Lopez J, Lahuerta JJ, Rosiñol L, Blade J, Mateos MV, San-Miguel JF, Paiva B; PETHEMA/GEM Cooperative Group. Burgos L, et al. Among authors: merlini g. J Clin Oncol. 2023 Jun 1;41(16):3019-3031. doi: 10.1200/JCO.22.01916. Epub 2023 Mar 17. J Clin Oncol. 2023. PMID: 36930848

2

Analysis of V(lambda)-J(lambda) expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambdaIII) as a new amyloid-associated germline gene segment.

Perfetti V, Casarini S, Palladini G, Vignarelli MC, Klersy C, Diegoli M, Ascari E, Merlini G. Perfetti V, et al. Among authors: merlini g. Blood. 2002 Aug 1;100(3):948-53. doi: 10.1182/blood-2002-01-0114. Blood. 2002. PMID: 12130507 Free article.

3

Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.

Palladini G, Campana C, Klersy C, Balduini A, Vadacca G, Perfetti V, Perlini S, Obici L, Ascari E, d'Eril GM, Moratti R, Merlini G. Palladini G, et al. Among authors: merlini g. Circulation. 2003 May 20;107(19):2440-5. doi: 10.1161/01.CIR.0000068314.02595.B2. Epub 2003 Apr 28. Circulation. 2003. PMID: 12719281 Free article. Clinical Trial.

4

Prognostic factors in symptomatic Waldenstrom's macroglobulinemia.

Merlini G, Baldini L, Broglia C, Comelli M, Goldaniga M, Palladini G, Deliliers GL, Gobbi PG. Merlini G, et al. Semin Oncol. 2003 Apr;30(2):211-5. doi: 10.1053/sonc.2003.50064. Semin Oncol. 2003. PMID: 12720138

5

Insights into the regulation of immunoglobulin light chain gene rearrangements via analysis of the kappa light chain locus in lambda myeloma.

Perfetti V, Vignarelli MC, Palladini G, Navazza V, Giachino C, Merlini G. Perfetti V, et al. Among authors: merlini g. Immunology. 2004 Jul;112(3):420-7. doi: 10.1046/j.1365-2567.2004.01902.x. Immunology. 2004. PMID: 15196210 Free PMC article.

6

First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndrome.

Obici L, Manno C, Muda AO, Picco P, D'Osualdo A, Palladini G, Avanzini MA, Torres D, Marciano S, Merlini G. Obici L, et al. Among authors: merlini g. Arthritis Rheum. 2004 Sep;50(9):2966-9. doi: 10.1002/art.20490. Arthritis Rheum. 2004. PMID: 15457465 Free article.

7

The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL).

Palladini G, Perfetti V, Perlini S, Obici L, Lavatelli F, Caccialanza R, Invernizzi R, Comotti B, Merlini G. Palladini G, et al. Among authors: merlini g. Blood. 2005 Apr 1;105(7):2949-51. doi: 10.1182/blood-2004-08-3231. Epub 2004 Nov 30. Blood. 2005. PMID: 15572585 Free article. Clinical Trial.

8

Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?

Gobbi PG, Baldini L, Broglia C, Goldaniga M, Comelli M, Morel P, Morra E, Cortelazzo S, Bettini R, Merlini G. Gobbi PG, et al. Among authors: merlini g. Clin Cancer Res. 2005 Mar 1;11(5):1786-90. doi: 10.1158/1078-0432.CCR-04-1899. Clin Cancer Res. 2005. PMID: 15756000

9

Multicentre versus single centre approach to rare diseases: the model of systemic light chain amyloidosis.

Palladini G, Kyle RA, Larson DR, Therneau TM, Merlini G, Gertz MA. Palladini G, et al. Among authors: merlini g. Amyloid. 2005 Jun;12(2):120-6. doi: 10.1080/13506120500107055. Amyloid. 2005. PMID: 16011989

10

Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system.

Baldini L, Goldaniga M, Guffanti A, Broglia C, Cortelazzo S, Rossi A, Morra E, Colombi M, Callea V, Pogliani E, Ilariucci F, Luminari S, Morel P, Merlini G, Gobbi P. Baldini L, et al. Among authors: merlini g. J Clin Oncol. 2005 Jul 20;23(21):4662-8. doi: 10.1200/JCO.2005.06.147. J Clin Oncol. 2005. PMID: 16034042

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

612 results

Search Page